1. Home
  2. QNRX vs DTSS Comparison

QNRX vs DTSS Comparison

Compare QNRX & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

N/A

Current Price

$4.44

Market Cap

9.2M

Sector

Health Care

ML Signal

N/A

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$0.79

Market Cap

9.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
QNRX
DTSS
Founded
2018
2014
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.2M
9.0M
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
QNRX
DTSS
Price
$4.44
$0.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
325.3K
282.8K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
82.42
EPS
N/A
N/A
Revenue
N/A
$71,616,820.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
198.70
52 Week Low
$3.25
$0.58
52 Week High
$41.80
$2.50

Technical Indicators

Market Signals
Indicator
QNRX
DTSS
Relative Strength Index (RSI) 49.98 42.77
Support Level $4.25 $0.61
Resistance Level $5.11 $0.98
Average True Range (ATR) 0.54 0.07
MACD 0.10 0.00
Stochastic Oscillator 78.58 41.35

Price Performance

Historical Comparison
QNRX
DTSS

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

Share on Social Networks: